Cargando…
The Use of Bioactive Polymers for Intervention and Tissue Engineering: The New Frontier for Cardiovascular Therapy
Coronary heart disease remains one of the leading causes of death in most countries. Healthcare improvements have seen a shift in the presentation of disease with a reducing number of ST-segment elevation myocardial infarctions (STEMIs), largely due to earlier reperfusion strategies such as percutan...
Autores principales: | Nappi, Francesco, Nenna, Antonio, Larobina, Domenico, Martuscelli, Giorgia, Singh, Sanjeet Singh Avtaar, Chello, Massimo, Ambrosio, Luigi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7866823/ https://www.ncbi.nlm.nih.gov/pubmed/33573282 http://dx.doi.org/10.3390/polym13030446 |
Ejemplares similares
-
Polymers and Nanoparticles for Statin Delivery: Current Use and Future Perspectives in Cardiovascular Disease
por: Nenna, Antonio, et al.
Publicado: (2021) -
Trends in Managing Cardiac and Orthopaedic Device-Associated Infections by Using Therapeutic Biomaterials
por: Scialla, Stefania, et al.
Publicado: (2021) -
Pharmacologic Approaches Against Advanced Glycation End Products (AGEs) in Diabetic Cardiovascular Disease
por: Nenna, Antonio, et al.
Publicado: (2015) -
MicroRNAs in Valvular Heart Diseases: Biological Regulators, Prognostic Markers and Therapeutical Targets
por: Nappi, Francesco, et al.
Publicado: (2021) -
Association between COVID-19 Diagnosis and Coronary Artery Thrombosis: A Narrative Review
por: Nappi, Francesco, et al.
Publicado: (2022)